Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- a Clinical Trial

NCT05973188 is registered in ClinicalTrials.gov with Peshawar Institute of Cardiology as lead sponsor.

NCT NCT05973188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05973188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- a Clinical Trial
Lead sponsor
Peshawar Institute of Cardiology
Phase
Phase 4
Overall status
Unknown status
Start date
May 1, 2023
Completion date
June 30, 2024
Enrollment
141 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular thrombus